Cancer medicine, ISSN 2045-7634, 09/2018, Volume 7, Issue 9, pp. 4447 - 4455
Background: Although the prognosis of core-binding factor (CBF) acute myeloid leukemia (AML) is better than other subtypes of AML, 30% of patients still...
GENE-MUTATIONS | AML | SURVIVAL | PROGNOSTIC IMPACT | relapse | FLT3 | C-KIT MUTATIONS | ADULTS | core-binding factor | CANCER | scoring system | INV | KIT mutation | predictive value | acute myeloid leukemia | disease-free survival | GROUP-B | disease‐free survival | core‐binding factor | ONCOLOGY | Medicine, Experimental | Medical research | Transplantation | Blood cell count | Hematopoietic stem cells | Myeloid leukemia | Cerebral blood flow | Hypodiploidy | Medical prognosis | Leukemia | Remission | Acute myeloid leukemia | Risk factors | Hemopoiesis
GENE-MUTATIONS | AML | SURVIVAL | PROGNOSTIC IMPACT | relapse | FLT3 | C-KIT MUTATIONS | ADULTS | core-binding factor | CANCER | scoring system | INV | KIT mutation | predictive value | acute myeloid leukemia | disease-free survival | GROUP-B | disease‐free survival | core‐binding factor | ONCOLOGY | Medicine, Experimental | Medical research | Transplantation | Blood cell count | Hematopoietic stem cells | Myeloid leukemia | Cerebral blood flow | Hypodiploidy | Medical prognosis | Leukemia | Remission | Acute myeloid leukemia | Risk factors | Hemopoiesis
Journal Article
The American Journal of Sports Medicine, ISSN 0363-5465, 10/2011, Volume 39, Issue 10, pp. 2099 - 2107
Background: The prognostic factors associated with structural outcome after arthroscopic rotator cuff repair have not yet been fully determined. Hypothesis:...
bone mineral density | prognostic factors | osteoporosis | rotator cuff healing | rotator cuff tear | PULL-OUT STRENGTH | SUTURE ANCHOR | TENDON | SPORT SCIENCES | FULL-THICKNESS TEARS | BONE-MINERAL DENSITY | STRUCTURAL INTEGRITY | FOLLOW-UP | PROXIMAL HUMERUS | ROW FIXATION | ORTHOPEDICS | POSTOPERATIVE SHOULDER | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Wound Healing | Rotator Cuff - surgery | Rotator Cuff - diagnostic imaging | Rotator Cuff Injuries | Arthroscopy | Ultrasonography | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Bone Density | Diabetes Complications - physiopathology | Risk Factors | Treatment Outcome | Radiography | Osteoporosis - complications | Sex Factors | Aged | Tendon Injuries - surgery | Studies | Hypotheses | Bone density | Shoulder | Evaluation | Diabetes mellitus | musculoskeletal system | Bone healing | Gender | Minerals | Multivariate analysis | Bone surgery | Patients | Recovery | Risk factors | Osteoporosis | Computed tomography | Analysis | Surgery | Bone mineral density | Infiltration | Ultrasound | Age | Failure | Rotator cuff | Tears | Geriatrics
bone mineral density | prognostic factors | osteoporosis | rotator cuff healing | rotator cuff tear | PULL-OUT STRENGTH | SUTURE ANCHOR | TENDON | SPORT SCIENCES | FULL-THICKNESS TEARS | BONE-MINERAL DENSITY | STRUCTURAL INTEGRITY | FOLLOW-UP | PROXIMAL HUMERUS | ROW FIXATION | ORTHOPEDICS | POSTOPERATIVE SHOULDER | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Wound Healing | Rotator Cuff - surgery | Rotator Cuff - diagnostic imaging | Rotator Cuff Injuries | Arthroscopy | Ultrasonography | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Bone Density | Diabetes Complications - physiopathology | Risk Factors | Treatment Outcome | Radiography | Osteoporosis - complications | Sex Factors | Aged | Tendon Injuries - surgery | Studies | Hypotheses | Bone density | Shoulder | Evaluation | Diabetes mellitus | musculoskeletal system | Bone healing | Gender | Minerals | Multivariate analysis | Bone surgery | Patients | Recovery | Risk factors | Osteoporosis | Computed tomography | Analysis | Surgery | Bone mineral density | Infiltration | Ultrasound | Age | Failure | Rotator cuff | Tears | Geriatrics
Journal Article
Physical Therapy, ISSN 0031-9023, 05/2011, Volume 91, Issue 5, pp. 737 - 753
Originally the term "yellow flags" was used to describe psychosocial prognostic factors for the development of disability following the onset of...
MUSCULOSKELETAL PAIN | TO-WORK INTERVENTIONS | PRIMARY-CARE | PROGNOSTIC-FACTORS | RANDOMIZED CLINICAL-TRIAL | OCCUPATIONAL-HEALTH | REHABILITATION | SICK LEAVE | FEAR-AVOIDANCE | PSYCHOSOCIAL FACTORS | ORTHOPEDICS | SECONDARY PREVENTION | Disability Evaluation | Disabled Persons - psychology | Acute Disease | Prognosis | Low Back Pain - rehabilitation | Risk Assessment | Attitude to Health | Humans | Low Back Pain - psychology | Risk Factors | Disabled Persons - rehabilitation | Prevention | Psychological aspects | Care and treatment | Low back pain | Therapeutics, Physiological | Research | Risk factors | Physical therapy | Methods | Intervention | Data collection | Back pain | Clinical medicine | Psychopathology | Injuries | Samhällsvetenskap | Social Sciences | Socialvetenskap | Psychology | Psykologi
MUSCULOSKELETAL PAIN | TO-WORK INTERVENTIONS | PRIMARY-CARE | PROGNOSTIC-FACTORS | RANDOMIZED CLINICAL-TRIAL | OCCUPATIONAL-HEALTH | REHABILITATION | SICK LEAVE | FEAR-AVOIDANCE | PSYCHOSOCIAL FACTORS | ORTHOPEDICS | SECONDARY PREVENTION | Disability Evaluation | Disabled Persons - psychology | Acute Disease | Prognosis | Low Back Pain - rehabilitation | Risk Assessment | Attitude to Health | Humans | Low Back Pain - psychology | Risk Factors | Disabled Persons - rehabilitation | Prevention | Psychological aspects | Care and treatment | Low back pain | Therapeutics, Physiological | Research | Risk factors | Physical therapy | Methods | Intervention | Data collection | Back pain | Clinical medicine | Psychopathology | Injuries | Samhällsvetenskap | Social Sciences | Socialvetenskap | Psychology | Psykologi
Journal Article
Cancer, ISSN 0008-543X, 2010, Volume 116, Issue 18, pp. 4256 - 4265
BACKGROUND: A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell carcinoma (mRCC)...
Metastatic renal cell carcinoma | Phase 3 | RAD001 | Everolimus | Prognostic factors | phase 3 | everolimus | RANDOMIZED-TRIALS | MODELS | ONCOLOGY | metastatic renal cell carcinoma | prognostic factors | NONCOMPLIANCE | MTOR | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Prognosis | Double-Blind Method | Carcinoma, Renal Cell - pathology | Humans | Middle Aged | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Retreatment | Neoplasm Metastasis | Aged, 80 and over | Placebos | Adult | Kidney Neoplasms - pathology | Aged | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Care and treatment | Cancer patients | Carcinoma, Renal cell | Research | Patient outcomes
Metastatic renal cell carcinoma | Phase 3 | RAD001 | Everolimus | Prognostic factors | phase 3 | everolimus | RANDOMIZED-TRIALS | MODELS | ONCOLOGY | metastatic renal cell carcinoma | prognostic factors | NONCOMPLIANCE | MTOR | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Prognosis | Double-Blind Method | Carcinoma, Renal Cell - pathology | Humans | Middle Aged | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Retreatment | Neoplasm Metastasis | Aged, 80 and over | Placebos | Adult | Kidney Neoplasms - pathology | Aged | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Care and treatment | Cancer patients | Carcinoma, Renal cell | Research | Patient outcomes
Journal Article
1996, ISBN 9780867204834, xvi, 304
Book
1995, ISBN 0878405720, 272
Book
JAMA Dermatology, ISSN 2168-6068, 04/2016, Volume 152, Issue 4, pp. 419 - 428
IMPORTANCE: To date, the magnitude of association and the quality of evidence for cutaneous squamous cell carcinoma (cSCC) and risk factors for outcomes have...
STAGING SYSTEM | LYMPH-NODE METASTASIS | LOCAL RECURRENCE | PERINEURAL INVASION | MOHS SURGERY | HISTOPATHOLOGICAL CHARACTERISTICS | TRANSPLANT RECIPIENTS | AMERICAN JOINT COMMITTEE | SKIN-CANCER | HISTOLOGICAL PROGNOSTIC-FACTORS | DERMATOLOGY | Skin Neoplasms - pathology | Carcinoma, Squamous Cell - etiology | Genetic Predisposition to Disease | Neoplasm Metastasis | Carcinoma, Squamous Cell - epidemiology | Neoplasm Invasiveness | Carcinoma, Squamous Cell - pathology | Humans | Risk Factors | Neoplasm Recurrence, Local - epidemiology | Skin Neoplasms - etiology | Skin Neoplasms - epidemiology | Squamous cell carcinoma | Care and treatment | Usage | Patient outcomes | Mortality | Analysis | Meta-analysis
STAGING SYSTEM | LYMPH-NODE METASTASIS | LOCAL RECURRENCE | PERINEURAL INVASION | MOHS SURGERY | HISTOPATHOLOGICAL CHARACTERISTICS | TRANSPLANT RECIPIENTS | AMERICAN JOINT COMMITTEE | SKIN-CANCER | HISTOLOGICAL PROGNOSTIC-FACTORS | DERMATOLOGY | Skin Neoplasms - pathology | Carcinoma, Squamous Cell - etiology | Genetic Predisposition to Disease | Neoplasm Metastasis | Carcinoma, Squamous Cell - epidemiology | Neoplasm Invasiveness | Carcinoma, Squamous Cell - pathology | Humans | Risk Factors | Neoplasm Recurrence, Local - epidemiology | Skin Neoplasms - etiology | Skin Neoplasms - epidemiology | Squamous cell carcinoma | Care and treatment | Usage | Patient outcomes | Mortality | Analysis | Meta-analysis
Journal Article
1995, 1st ed., ISBN 0826512607, xvi, 323
Book
Blood, ISSN 0006-4971, 07/2007, Volume 110, Issue 1, pp. 133 - 141
Tumor cell-associated tissue factor (TF) is a powerful determinant of metastatic potential. TF may increase metastasis by supporting thrombin-mediated...
CYTOPLASMIC DOMAIN | ACTIVATED RECEPTOR-1 | HEPATOCELLULAR-CARCINOMA | PROGNOSTIC-FACTOR | THROMBIN | FACTOR EXPRESSION | GROWTH-FACTOR PRODUCTION | BLEEDING EVENTS | MELANOMA-CELLS | HEMATOLOGY | LYMPHATIC METASTASIS | Fibrin | Animals | Neoplasm Metastasis - immunology | Blood Platelets | Cell Line, Tumor | Killer Cells, Natural - immunology | Prothrombin | Blood Coagulation Factors - physiology | Mice | Neoplastic Cells, Circulating - immunology | Thromboplastin - physiology | Killer Cells, Natural - physiology | Hemostasis, Thrombosis, and Vascular Biology
CYTOPLASMIC DOMAIN | ACTIVATED RECEPTOR-1 | HEPATOCELLULAR-CARCINOMA | PROGNOSTIC-FACTOR | THROMBIN | FACTOR EXPRESSION | GROWTH-FACTOR PRODUCTION | BLEEDING EVENTS | MELANOMA-CELLS | HEMATOLOGY | LYMPHATIC METASTASIS | Fibrin | Animals | Neoplasm Metastasis - immunology | Blood Platelets | Cell Line, Tumor | Killer Cells, Natural - immunology | Prothrombin | Blood Coagulation Factors - physiology | Mice | Neoplastic Cells, Circulating - immunology | Thromboplastin - physiology | Killer Cells, Natural - physiology | Hemostasis, Thrombosis, and Vascular Biology
Journal Article
Circulation, ISSN 0009-7322, 03/2011, Volume 123, Issue 9, pp. 951 - 960
Background-Permanent pacemaker (PPM) requirement is a recognized complication of transcatheter aortic valve implantation. We assessed the UK incidence of...
pacemakers | transcatheter aortic valve implantation | transcatheter aortic valve | aortic stenosis | electrocardiography | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | ABNORMALITIES | BLOCK | VALVULAR HEART-DISEASE | REPLACEMENT | HIGH-RISK PATIENTS | CONDUCTION | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | PROSTHESIS | Heart Valve Prosthesis Implantation - instrumentation | Cardiac Catheterization - trends | Cardiac Pacing, Artificial - trends | Heart Valve Prosthesis Implantation - trends | Humans | Aortic Valve Stenosis - physiopathology | Heart Valve Prosthesis Implantation - methods | Male | United Kingdom | Aortic Valve Stenosis - therapy | Cardiac Pacing, Artificial - methods | Aortic Valve - pathology | Incidence | Cardiac Catheterization - methods | Aged, 80 and over | Female | Aged | Retrospective Studies | Pacemaker, Artificial - trends | Complications and side effects | Usage | Pacemaker, Artificial (Heart) | Research | Heart valve replacement
pacemakers | transcatheter aortic valve implantation | transcatheter aortic valve | aortic stenosis | electrocardiography | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | ABNORMALITIES | BLOCK | VALVULAR HEART-DISEASE | REPLACEMENT | HIGH-RISK PATIENTS | CONDUCTION | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | PROSTHESIS | Heart Valve Prosthesis Implantation - instrumentation | Cardiac Catheterization - trends | Cardiac Pacing, Artificial - trends | Heart Valve Prosthesis Implantation - trends | Humans | Aortic Valve Stenosis - physiopathology | Heart Valve Prosthesis Implantation - methods | Male | United Kingdom | Aortic Valve Stenosis - therapy | Cardiac Pacing, Artificial - methods | Aortic Valve - pathology | Incidence | Cardiac Catheterization - methods | Aged, 80 and over | Female | Aged | Retrospective Studies | Pacemaker, Artificial - trends | Complications and side effects | Usage | Pacemaker, Artificial (Heart) | Research | Heart valve replacement
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2013, Volume 24, Issue 1, pp. 152 - 160
As studies on gastrointestinal neuroendocrine carcinoma (WHO G3) (GI-NEC) are limited, we reviewed clinical data to identify predictive and prognostic markers...
Chemotherapy | Predictive factors | Gastrointestinal cancer | Neuroendocrine carcinoma | Prognostic factors | Neuroendocrine cancer | GUIDELINES | neuroendocrine carcinoma | prognostic factors | PROLIFERATION | TUMORS | LUNG-CANCER | TRACT | ETOPOSIDE | CISPLATIN | ONCOLOGY | gastrointestinal cancer | COLORECTAL-CANCER | predictive factors | SMALL-CELL CARCINOMA | neuroendocrine cancer | Carcinoma, Neuroendocrine - physiopathology | Prognosis | Humans | Middle Aged | History, 16th Century | Carcinoma, Neuroendocrine - therapy | Male | Gastrointestinal Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Female | ROC Curve | Aged | Gastrointestinal Neoplasms - physiopathology | Medical and Health Sciences | Medicin och hälsovetenskap
Chemotherapy | Predictive factors | Gastrointestinal cancer | Neuroendocrine carcinoma | Prognostic factors | Neuroendocrine cancer | GUIDELINES | neuroendocrine carcinoma | prognostic factors | PROLIFERATION | TUMORS | LUNG-CANCER | TRACT | ETOPOSIDE | CISPLATIN | ONCOLOGY | gastrointestinal cancer | COLORECTAL-CANCER | predictive factors | SMALL-CELL CARCINOMA | neuroendocrine cancer | Carcinoma, Neuroendocrine - physiopathology | Prognosis | Humans | Middle Aged | History, 16th Century | Carcinoma, Neuroendocrine - therapy | Male | Gastrointestinal Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Female | ROC Curve | Aged | Gastrointestinal Neoplasms - physiopathology | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 67, Issue 1, pp. 74 - 82
Abstract Background The impact of prognostic factors in T1G3 non–muscle-invasive bladder cancer (BCa) patients is critical for proper treatment decision...
Urology | Bacillus Calmette-Guérin | Non–muscle-invasive bladder cancer | Prognostic factors | BCG | T1G3 | Calmette-Guérin | Bacillus | Non-muscle-invasive bladder cancer | SURVIVAL | METAANALYSIS | MANAGEMENT | UROTHELIAL CARCINOMA | NATURAL-HISTORY | Bacillus Calmette-Guerin | IMPACT | UROLOGY & NEPHROLOGY | DEFERRED CYSTECTOMY | RECURRENCE | PROGRESSION | STAGE T1 | Prognosis | Age Factors | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Tumor Burden | Urinary Bladder Neoplasms - drug therapy | Neoplasm Recurrence, Local - surgery | Urinary Bladder Neoplasms - surgery | Carcinoma in Situ - complications | Disease Progression | Neoplasm Recurrence, Local - pathology | Cystectomy | Urinary Bladder Neoplasms - pathology | Female | Aged | Retrospective Studies | BCG Vaccine - therapeutic use | Adjuvants, Immunologic - therapeutic use | Oncology, Experimental | Research | Cancer | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Urology | Bacillus Calmette-Guérin | Non–muscle-invasive bladder cancer | Prognostic factors | BCG | T1G3 | Calmette-Guérin | Bacillus | Non-muscle-invasive bladder cancer | SURVIVAL | METAANALYSIS | MANAGEMENT | UROTHELIAL CARCINOMA | NATURAL-HISTORY | Bacillus Calmette-Guerin | IMPACT | UROLOGY & NEPHROLOGY | DEFERRED CYSTECTOMY | RECURRENCE | PROGRESSION | STAGE T1 | Prognosis | Age Factors | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Tumor Burden | Urinary Bladder Neoplasms - drug therapy | Neoplasm Recurrence, Local - surgery | Urinary Bladder Neoplasms - surgery | Carcinoma in Situ - complications | Disease Progression | Neoplasm Recurrence, Local - pathology | Cystectomy | Urinary Bladder Neoplasms - pathology | Female | Aged | Retrospective Studies | BCG Vaccine - therapeutic use | Adjuvants, Immunologic - therapeutic use | Oncology, Experimental | Research | Cancer | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Nature Reviews Cardiology, ISSN 1759-5002, 12/2011, Volume 8, Issue 12, pp. 673 - 685
The prevalence of heart failure is increasing in the western world. Current efforts aim to identify heart failure at its earliest and preclinical stages in...
PROGNOSTIC IMPLICATIONS | DIABETES-MELLITUS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CARDIOVASCULAR MAGNETIC-RESONANCE | CLINICAL-IMPLICATIONS | ASSOCIATION TASK-FORCE | LEFT-VENTRICULAR MASS | SYSTOLIC FUNCTION | CONGESTIVE-HEART-FAILURE | BLOOD-PRESSURE | Predictive Value of Tests | Prognosis | Risk Assessment | Humans | Middle Aged | Risk Factors | Heart Failure - physiopathology | Hypertrophy, Left Ventricular - diagnosis | Male | Asymptomatic Diseases | Hypertrophy, Left Ventricular - epidemiology | Mass Screening - methods | Heart Failure - therapy | Hypertrophy, Left Ventricular - therapy | Ventricular Remodeling | Aged, 80 and over | Adult | Female | Aged | Heart Failure - diagnosis | Hypertrophy, Left Ventricular - physiopathology | Early Diagnosis | Heart Failure - epidemiology | Heart failure | Care and treatment | Research | Diagnosis
PROGNOSTIC IMPLICATIONS | DIABETES-MELLITUS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CARDIOVASCULAR MAGNETIC-RESONANCE | CLINICAL-IMPLICATIONS | ASSOCIATION TASK-FORCE | LEFT-VENTRICULAR MASS | SYSTOLIC FUNCTION | CONGESTIVE-HEART-FAILURE | BLOOD-PRESSURE | Predictive Value of Tests | Prognosis | Risk Assessment | Humans | Middle Aged | Risk Factors | Heart Failure - physiopathology | Hypertrophy, Left Ventricular - diagnosis | Male | Asymptomatic Diseases | Hypertrophy, Left Ventricular - epidemiology | Mass Screening - methods | Heart Failure - therapy | Hypertrophy, Left Ventricular - therapy | Ventricular Remodeling | Aged, 80 and over | Adult | Female | Aged | Heart Failure - diagnosis | Hypertrophy, Left Ventricular - physiopathology | Early Diagnosis | Heart Failure - epidemiology | Heart failure | Care and treatment | Research | Diagnosis
Journal Article